Literature DB >> 10218506

Sex-related differences in bronchial epithelial changes associated with tobacco smoking.

S Lam1, J C leRiche, Y Zheng, A Coldman, C MacAulay, E Hawk, G Kelloff, A F Gazdar.   

Abstract

BACKGROUND: Lung cancer is the most common cause of cancer death in North American women. Because smoking-related changes in the bronchial epithelium and in lung function have not been studied in detail in women, we used fluorescence bronchoscopy-directed biopsy to determine the prevalence of high-grade preinvasive lesions in former and current smokers of both sexes.
METHODS: Spirometry, white-light bronchoscopy, and fluorescence bronchoscopy were performed in 189 women and 212 men older than 40 years of age who had smoked 20 pack-years or more (pack-years = number of packs of cigarettes smoked per day x number of years of smoking).
RESULTS: Carcinoma in situ was found in 1.8% of the subjects, severe dysplasia was found in 6.5%, and moderate dysplasia was found in 14% (all preinvasive lesions). Compared with men, women had a lower prevalence of high-grade preinvasive lesions in the observed airways (14% versus 31%; odds ratio = 0.18; 95% confidence interval = 0.04-0.88), and women with preinvasive lesions had fewer such lesions (two-sided P = .048). The prevalence of preinvasive lesions did not change substantially for more than 10 years after cessation of smoking. Lung function was associated with the prevalence of preinvasive lesions, but the association was weaker in women than in men. If the presence of airflow obstruction was defined by an FEV1/FVC (forced expiratory volume in 1 second/forced vital capacity) value of 70% or less, only 56% of the men and 44% of the women with preinvasive lesions had abnormal lung function.
CONCLUSION: In developing strategies for chemoprevention or early detection of lung cancer in high-risk populations, it is important to consider the effect of sex and arbitrarily chosen lung function values on the prevalence of preinvasive airway lesions.

Entities:  

Mesh:

Year:  1999        PMID: 10218506     DOI: 10.1093/jnci/91.8.691

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  16 in total

Review 1.  Biomarkers to assess the utility of potential reduced exposure tobacco products.

Authors:  Dorothy K Hatsukami; Neal L Benowitz; Stephen I Rennard; Cheryl Oncken; Stephen S Hecht
Journal:  Nicotine Tob Res       Date:  2006-08       Impact factor: 4.244

2.  Progression of airway dysplasia and C-reactive protein in smokers at high risk of lung cancer.

Authors:  Don D Sin; S F Paul Man; Annette McWilliams; Stephen Lam
Journal:  Am J Respir Crit Care Med       Date:  2005-12-09       Impact factor: 21.405

Review 3.  Natural history of bronchial preinvasive lesions.

Authors:  Taichiro Ishizumi; Annette McWilliams; Calum MacAulay; Adi Gazdar; Stephen Lam
Journal:  Cancer Metastasis Rev       Date:  2010-03       Impact factor: 9.264

4.  Recent striking changes in histological differentiation and rate of human papillomavirus infection in squamous cell carcinoma of the lung in Okinawa, a subtropical island in southern Japan.

Authors:  J Miyagi; K Tsuhako; T Kinjo; T Iwamasa; T Hirayasu
Journal:  J Clin Pathol       Date:  2000-09       Impact factor: 3.411

5.  Molecular changes in the bronchial epithelium of patients with small cell lung cancer.

Authors:  I I Wistuba; J Berry; C Behrens; A Maitra; N Shivapurkar; S Milchgrub; B Mackay; J D Minna; A F Gazdar
Journal:  Clin Cancer Res       Date:  2000-07       Impact factor: 12.531

6.  Identification of the SOX2 Interactome by BioID Reveals EP300 as a Mediator of SOX2-dependent Squamous Differentiation and Lung Squamous Cell Carcinoma Growth.

Authors:  Bo Ram Kim; Etienne Coyaud; Estelle M N Laurent; Jonathan St-Germain; Emily Van de Laar; Ming-Sound Tsao; Brian Raught; Nadeem Moghal
Journal:  Mol Cell Proteomics       Date:  2017-08-09       Impact factor: 5.911

Review 7.  Early detection for lung cancer. New tools for casefinding.

Authors:  S Lam; B Lam; T L Petty
Journal:  Can Fam Physician       Date:  2001-03       Impact factor: 3.275

8.  G-protein coupled receptor family C, group 5, member A (GPRC5A) expression is decreased in the adjacent field and normal bronchial epithelia of patients with chronic obstructive pulmonary disease and non-small-cell lung cancer.

Authors:  Junya Fujimoto; Humam Kadara; Melinda M Garcia; Mohamed Kabbout; Carmen Behrens; Diane D Liu; J Jack Lee; Luisa M Solis; Edward S Kim; Neda Kalhor; Cesar Moran; Amir Sharafkhaneh; Reuben Lotan; Ignacio I Wistuba
Journal:  J Thorac Oncol       Date:  2012-12       Impact factor: 15.609

9.  Lung cancer and chronic obstructive pulmonary disease: needs and opportunities for integrated research.

Authors:  Antonello Punturieri; Eva Szabo; Thomas L Croxton; Steven D Shapiro; Steven M Dubinett
Journal:  J Natl Cancer Inst       Date:  2009-04-07       Impact factor: 13.506

10.  A randomized phase II chemoprevention trial of 13-CIS retinoic acid with or without alpha tocopherol or observation in subjects at high risk for lung cancer.

Authors:  Karen Kelly; John Kittelson; Wilbur A Franklin; Timothy C Kennedy; Catherine E Klein; Robert L Keith; Edward C Dempsey; Marina Lewis; Mary K Jackson; Fred R Hirsch; Paul A Bunn; York E Miller
Journal:  Cancer Prev Res (Phila)       Date:  2009-04-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.